US STOCKS
FUNDS
FOREX
SH/SZ-HK
HK STOCKS
 
 
 
 
 
All
|
China Industry News
|
China's Economy
|
China's Market Top News
|
Company News
News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
FOSUN PHARMA (02196.HK): Authorized by BioNTech to Develop COVID-19 Vaccine
FOSUN PHARMA (02196.HK) (600196.SH) announced that on 13 March (Eastern Time), Fosun Pharmaceutical Industrial, a controlling subsidiary of the Company, entered into the License Ag...
Reset
Send
The window will close in 5 seconds
FOSUN PHARMA (02196.HK): Authorized by BioNTech to Develop COVID-19 Vaccine
   Back  
2020/03/16 08:07
Share  
  
  
  
  
  
Print     
Font Size  
FOSUN PHARMA (02196.HK) (600196.SH) announced that on 13 March (Eastern Time), Fosun Pharmaceutical Industrial, a controlling subsidiary of the Company, entered into the License Agreement with BioNTech, a German company listed on NASDAQ in the United States.

Pursuant to which, Fosun Pharmaceutical Industrial was granted an exclusive license from BioNTech to exclusive develop and commercialize the vaccine product targeting COVID-19 developed based on BioNTech’s mRNA technology platform in the Territory.
~



AAStocks Financial News
Web Site: www.aastocks.com